Results generated from a syngeneic breast cancer model have corroborated that inhibition of SK1 in tumor cells decreased S1P levels and lung and lymph nodes metastasis through the disruption of angiogenesis and lymphangiogenesis [24]. This evidence concerns the gene MBTPS1 and breast cancer.